Cardiometabolic Risk in Canada: A Detailed Analysis and Position Paper by the Cardiometabolic Risk Working Group
Tóm tắt
Từ khóa
Tài liệu tham khảo
Leiter LA, Fitchett DH, Gilbert GE, et al; for the Cardiometabolic Risk Working Group. Identification and management of cardiometabolic risk in Canada: A position paper by the Cardiometabolic Working Group [Executive Summary]. Can J Cardiol: in press.
Eckel, 2006, Preventing cardiovascular disease and diabetes: a call to action from the American Diabetes Association and the American Heart Association, Circulation, 113, 2943, 10.1161/CIRCULATIONAHA.106.176583
Kahn, 2005, The metabolic syndrome: time for a critical appraisal, Diabetes Care, 28, 2289, 10.2337/diacare.28.9.2289
Brunzell, 2008, Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation, Diabetes Care, 31, 811, 10.2337/dc08-9018
Després, 2008, The concept of cardiometabolic risk: bridging the fields of diabetology and cardiology, Ann Med, 40, 514, 10.1080/07853890802004959
Després, 2006, Abdominal obesity: the most prevalent cause of the metabolic syndrome and related cardiometabolic risk, Eur Heart J Suppl, 8, B4, 10.1093/eurheartj/sul002
Alberti, 1998, Definition, diagnosis and classification of diabetes mellitus and its complications, Diabet Med, 15, 539, 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
2001, Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), JAMA, 285, 2486, 10.1001/jama.285.19.2486
Grundy, 2005, Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement, Circulation, 112, 2735, 10.1161/CIRCULATIONAHA.105.169404
2006
Daly, 2007, Adverse prognosis associated with the metabolic syndrome in established coronary artery disease: data from the EUROPA trial, Heart, 93, 1406, 10.1136/hrt.2006.113084
Mellen, 2006, Diabetes, the metabolic syndrome, and angiographic progression of coronary arterial disease in postmenopausal women, Arterioscler Thromb Vasc Biol, 26, 189, 10.1161/01.ATV.0000191656.71812.7c
Nilsson, 2007, The metabolic syndrome and incidence of cardiovascular disease in non-diabetic subjects: a population-based study comparing three different definitions, Diabet Med, 24, 464, 10.1111/j.1464-5491.2007.02142.x
Nilsson, 2007, Cardiovascular risk in the metabolic syndrome: fact or fiction?, Curr Cardiol Rep, 9, 479, 10.1007/BF02938392
Galassi, 2006, Metabolic syndrome and the risk of cardiovascular disease: a meta-analysis, Am J Med, 119, 812, 10.1016/j.amjmed.2006.02.031
Gami, 2007, Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies, J Am Coll Cardiol, 49, 403, 10.1016/j.jacc.2006.09.032
Noto, 2008, The metabolic syndrome predicts cardiovascular events in subjects with normal fasting glucose: results of a 15 years follow-up in a Mediterranean population, Atherosclerosis, 197, 147, 10.1016/j.atherosclerosis.2007.03.005
Lorenzo, 2007, The National Cholesterol Education Program: Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes, Diabetes Care, 30, 8, 10.2337/dc06-1414
de Simone, 2007, Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study, Diabetes Care, 30, 1851, 10.2337/dc06-2152
Arnlov, 2010, Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men, Circulation, 121, 230, 10.1161/CIRCULATIONAHA.109.887521
Paras, 2008, The relationship of three common definitions of the metabolic syndrome with subclinical carotid atherosclerosis, Atherosclerosis, 198, 228, 10.1016/j.atherosclerosis.2007.09.007
Berger, 2010, Screening for cardiovascular risk in asymptomatic patients, J Am Coll Cardiol, 55, 1169, 10.1016/j.jacc.2009.09.066
Assmann, 2002, Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the Prospective Cardiovascular Munster (PROCAM) study, Circulation, 105, 310, 10.1161/hc0302.102575
Borch-Johnsen, 2010, The rise and fall of the metabolic syndrome, Diabetologia, 53, 507, 10.1007/s00125-010-1659-2
Simmons, 2010, The metabolic syndrome: useful concept or clinical tool?, Diabetologia, 53, 600, 10.1007/s00125-009-1620-4
Day, 2007, Metabolic syndrome, or what you will: definitions and epidemiology, Diab Vasc Dis Res, 4, 32, 10.3132/dvdr.2007.003
Mente, 2010, Metabolic syndrome and risk of acute myocardial infarction: a case-control study of 26 903 subjects from 52 countries, J Am Coll Cardiol, 55, 2390, 10.1016/j.jacc.2009.12.053
Wang, 2007, The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns, Eur Heart J, 28, 857, 10.1093/eurheartj/ehl524
Saely, 2007, The metabolic syndrome and risk of cardiovascular disease and diabetes: experiences with the new diagnostic criteria from the International Diabetes Federation, Horm Metab Res, 39, 642, 10.1055/s-2007-985822
Brindle, 2006, Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review, Heart, 92, 1752, 10.1136/hrt.2006.087932
Simons, 2007, Does a diagnosis of the metabolic syndrome provide additional prediction of cardiovascular disease and total mortality in the elderly?, Med J Aust, 186, 400, 10.5694/j.1326-5377.2007.tb00972.x
Hunt, 2007, The metabolic syndrome and the impact of diabetes on coronary heart disease mortality in women and men: the San Antonio Heart Study, Ann Epidemiol, 17, 870, 10.1016/j.annepidem.2007.05.012
Pischon, 2008, Inflammation, the metabolic syndrome, and risk of coronary heart disease in women and men, Atherosclerosis, 197, 392, 10.1016/j.atherosclerosis.2007.06.022
Tong, 2007, The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes, Diabetes Care, 30, 1206, 10.2337/dc06-1484
Hemann, 2007, The Framingham Risk Score: an appraisal of its benefits and limitations, Am Heart Hosp J, 5, 91, 10.1111/j.1541-9215.2007.06350.x
Onat, 2007, Serum apolipoprotein B predicts dyslipidemia, metabolic syndrome and, in women, hypertension and diabetes, independent of markers of central obesity and inflammation, Int J Obes (Lond), 31, 1119, 10.1038/sj.ijo.0803552
Lind, 2006, The apolipoprotein B/AI ratio and the metabolic syndrome independently predict risk for myocardial infarction in middle-aged men, Arterioscler Thromb Vasc Biol, 26, 406, 10.1161/01.ATV.0000197827.12431.d0
Ridker, 2008, Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein, N Engl J Med, 359, 2195, 10.1056/NEJMoa0807646
Haffner, 2006, The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease, Am J Cardiol, 97, 3A, 10.1016/j.amjcard.2005.11.010
Saely, 2004, Lp(a) lipoprotein, vascular disease, and mortality in the elderly, N Engl J Med, 350, 1150, 10.1056/NEJM200403113501117
Taylor, 2005, Coronary calcium independently predicts incident premature coronary heart disease over measured cardiovascular risk factors: mean three-year outcomes in the Prospective Army Coronary Calcium (PACC) project, J Am Coll Cardiol, 46, 807, 10.1016/j.jacc.2005.05.049
Fowkes, 2008, Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis, JAMA, 300, 197, 10.1001/jama.300.2.197
Wyman, 2006, Ultrasound-detected carotid plaque as a predictor of cardiovascular events, Vasc Med, 11, 123, 10.1191/1358863x06vm666ra
Junyent, 2008, Carotid atherosclerosis and vascular age in the assessment of coronary heart disease risk beyond the Framingham Risk Score, Atherosclerosis, 196, 803, 10.1016/j.atherosclerosis.2007.01.019
Nambi, 2010, Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study, J Am Coll Cardiol, 3;, 55
Gepner, 2006, Use of carotid intima-media thickness and vascular age to modify cardiovascular risk prediction, J Am Soc Echocardiogr, 19, 1170, 10.1016/j.echo.2006.04.009
Simmons, 2008, Evaluation of the Framingham Risk Score in the European Prospective Investigation of Cancer—Norfolk cohort: does adding glycated hemoglobin improve the prediction of coronary heart disease events?, Arch Intern Med, 168, 1209, 10.1001/archinte.168.11.1209
Anderson, 2008, Lipoprotein-associated phospholipase A2: an independent predictor of coronary artery disease events in primary and secondary prevention, Am J Cardiol, 101, 23F, 10.1016/j.amjcard.2008.04.015
Yusuf, 2004, Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study, Lancet, 364, 937, 10.1016/S0140-6736(04)17018-9
Arnold, 2006, Canadian Cardiovascular Society consensus recommendations on heart failure 2006: diagnosis and management, Can J Cardiol, 22, 23, 10.1016/S0828-282X(06)70237-9
Tsimikas, 2006, C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients, J Am Coll Cardiol, 47, C19, 10.1016/j.jacc.2005.10.066
Lloyd-Jones, 2006, Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age, Circulation, 113, 791, 10.1161/CIRCULATIONAHA.105.548206
Daskalopoulou, 2006, Definitions of metabolic syndrome: Where are we now?, Curr Vasc Pharmacol, 4, 185, 10.2174/157016106777698450
Lawlor, 2006, Does the new International Diabetes Federation definition of the metabolic syndrome predict CHD any more strongly than older definitions? findings from the British Women's Heart and Health Study, Diabetologia, 49, 41, 10.1007/s00125-005-0040-3
Després, 2008, Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk, Arteroscler Thromb Vasc Biol, 28, 1039, 10.1161/ATVBAHA.107.159228
Sattar, 2008, Can metabolic syndrome usefully predict cardiovascular disease and diabetes? outcome data from two prospective studies, Lancet, 371, 1927, 10.1016/S0140-6736(08)60602-9
Sattar, 2006, The metabolic syndrome: should current criteria influence clinical practice?, Curr Opin Lipidol, 17, 404, 10.1097/01.mol.0000236366.48593.07
2007
Rome, 2003, Microarray profiling of human skeletal muscle reveals that insulin regulates approximately 800 genes during a hyperinsulinemic clamp, J Biol Chem, 278, 18063, 10.1074/jbc.M300293200
Lau, 2005, Adipokines: molecular links between obesity and atheroslcerosis, Am J Physiol Heart Circ Physiol, 288, H2031, 10.1152/ajpheart.01058.2004
Szmitko, 2007, Adiponectin and cardiovascular disease: state of the art?, Am J Physiol Heart Circ Physiol, 292, H1655, 10.1152/ajpheart.01072.2006
Steinberg, 1997, Elevated circulating free fatty acid levels impair endothelium-dependent vasodilatation, J Clin Invest, 100, 1230, 10.1172/JCI119636
Inoguchi, 2000, High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells, Diabetes, 49, 1939, 10.2337/diabetes.49.11.1939
Brownlee, 2001, Biochemistry and molecular biology of diabetic complications, Nature, 414, 813, 10.1038/414813a
Marfella, 2001, Acute hyperglycemia induces oxidative stress in healthy subjects, J Clin Invest, 108, 635, 10.1172/JCI13727
Kohler, 2000, Plasminogen activator inhibitor type 1 and coronary artery disease, N Engl J Med, 342, 1792, 10.1056/NEJM200006153422406
Meugnier, 2007, Acute hyperglycemia induces a global downregulation of gene expression in adipose tissue and skeletal muscle of healthy subjects, Diabetes, 56, 992, 10.2337/db06-1242
Prentki, 2008, Glycerolipid metabolism and signaling in health and disease, Endocr Rev, 29, 647, 10.1210/er.2008-0007
Bravata, 2004, Two measures of insulin sensitivity provided similar information in a U.S. population, J Clin Epidemiol, 57, 1214, 10.1016/j.jclinepi.2004.05.001
St-Onge, 2004, Metabolic syndrome in normal-weight Americans: new definition of the metabolically obese, normal-weight individual, Diabetes Care, 27, 2222, 10.2337/diacare.27.9.2222
Mayer-Davis, 1998, Intensity and amount of physical activity in relation to insulin sensitivity: the Insulin Resistance Atherosclerosis Study, JAMA, 279, 669, 10.1001/jama.279.9.669
Vessby, 2001, Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: the KANWU Study, Diabetologia, 44, 312, 10.1007/s001250051620
Karelis, 2005, The metabolically healthy but obese individual presents a favorable inflammation profile, J Clin Endocrinol Metab, 90, 4145, 10.1210/jc.2005-0482
Conus, 2007, Characteristics of metabolically obese normal-weight (MONW) subjects, Appl Physiol Nutr Metab, 32, 4, 10.1139/h06-092
Després, 2007, Classification of overweight and obesity, 176
Mathieu, 2008, Visceral obesity and the heart, Int J Biochem Cell Biol, 40, 821, 10.1016/j.biocel.2007.12.001
Poirier, 2008, Healthy lifestyle: even if you are doing everything right, extra weight carries an excess risk of acute coronary events, Circulation, 117, 3057, 10.1161/CIRCULATIONAHA.108.784389
Poirier, 2008, Cardiovascular consequences of obesity, Drug Discov Today: Ther Strategies, 5, 45
Poirier, 2005, Impact of waist circumference on the relationship between blood pressure and insulin, Hypertension, 45, 363, 10.1161/01.HYP.0000155463.90018.dc
2003
Poirier, 2009, Cardiovascular evaluation and management of severely obese patients undergoing surgery: a science advisory from the American Heart Association, Circulation, 120, 86, 10.1161/CIRCULATIONAHA.109.192575
Ross, 2008, Does the relationship between waist circumference, morbidity and mortality depend on measurement protocol for waist circumference?, Obesity Rev, 9, 312, 10.1111/j.1467-789X.2007.00411.x
2000
Julius, 2006, Feasibility of treating prehypertension with an angiotensin-receptor blocker, N Engl J Med, 354, 1685, 10.1056/NEJMoa060838
2008
Reenders, 1993, Diabetes and its long-term complications in general practice: a survey in a well-defined population, Fam Pract, 10, 169, 10.1093/fampra/10.2.169
Hsu, 2005, Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease, Arch Intern Med, 165, 923, 10.1001/archinte.165.8.923
Bakris, 2000, ACE inhibition or angiotensin receptor blockade: impact on potassium in renal failure, Kidney Int, 58, 2084, 10.1111/j.1523-1755.2000.00381.x
Bakris, 2000, Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?, Arch Intern Med, 160, 685, 10.1001/archinte.160.5.685
Simon, 1972, Clinical characteristics of renovascular hypertension, JAMA, 220, 1209, 10.1001/jama.1972.03200090031005
2008, Clinical practice guidelines for the prevention and management of diabetes in Canada, Can J Diabetes, 32, S1
Genest, 2009, 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult – 2009 recommendations, Can J Cardiol, 25, 567, 10.1016/S0828-282X(09)70715-9
Grundy, 2004, Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management, Circulation, 109, 551, 10.1161/01.CIR.0000112379.88385.67
Lau, 2007, 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary], CMAJ, 176, S1, 10.1503/cmaj.061409
Janiszewski, 2007, Physical activity in the treatment of obesity: beyond body weight reduction, Appl Physiol Nutr Metab, 32, 512, 10.1139/H07-018
Ross, 2004, Exercise-induced reduction in obesity and insulin resistance in women: a randomized controlled trial, Obes Res, 12, 789, 10.1038/oby.2004.95
Ross, 2000, Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men: a randomized, controlled trial, Ann Intern Med, 133, 92, 10.7326/0003-4819-133-2-200007180-00008
Irwin, 2003, Effect of exercise on total and intra-abdominal body fat in postmenopausal women: a randomized controlled trial, JAMA, 289, 323, 10.1001/jama.289.3.323
DiPietro, 2006, Exercise and improved insulin sensitivity in older women: evidence of the enduring benefits of higher intensity training, J Appl Physiol, 100, 142, 10.1152/japplphysiol.00474.2005
Ross, 2001, Physical activity, total and regional obesity: dose-response considerations, Med Sci Sports Exerc, 33, S521, 10.1097/00005768-200106001-00023
Green, 2004, The effects of exercise training on abdominal visceral fat, body composition, and indicators of the metabolic syndrome in postmenopausal women with and without estrogen replacement therapy: the HERITAGE family study, Metabolism, 53, 1192, 10.1016/j.metabol.2004.04.008
Ross, 2009, The future of obesity reduction: beyond weight loss, Nature Rev Endocrinol, 5, 319, 10.1038/nrendo.2009.78
Han, 1997, Waist circumference reduction and cardiovascular benefits during weight loss in women, Int J Obes Relat Metab Disord, 21, 127, 10.1038/sj.ijo.0800377
Dansinger, 2005, Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial, JAMA, 293, 43, 10.1001/jama.293.1.43
Cox, 2003, The independent and combined effects of 16 weeks of vigorous exercise and energy restriction on body mass and composition in free-living overweight men – a randomized controlled trial, Metabolism, 52, 107, 10.1053/meta.2003.50017
Sönnichsen, 1992, Benefit from hypocaloric diet in obese men depends on the extent of weight-loss regarding cholesterol, and on a simultaneous change in body fat distribution regarding insulin sensitivity and glucose tolerance, Metabolism, 41, 1035, 10.1016/0026-0495(92)90134-V
Goodpaster, 1999, Effects of weight loss on regional fat distribution and insulin sensitivity in obesity, Diabetes, 48, 839, 10.2337/diabetes.48.4.839
Purnell, 2000, Effect of weight loss with reduction of intra-abdominal fat on lipid metabolism in older men, J Clin Endocrinol Metab, 85, 977
Larson-Meyer, 2006, Effect of calorie restriction with or without exercise on insulin sensitivity, beta-cell function, fat cell size, and ectopic lipid in overweight subjects, Diabetes Care, 29, 1337, 10.2337/dc05-2565
1998
Larsen, 1997, The effect of moderate exercise on postprandial glucose homeostasis in NIDDM patients, Diabetologia, 40, 447, 10.1007/s001250050699
Musi, 2001, AMP-activated protein kinase (AMPK) is activated in muscle of subjects with type 2 diabetes during exercise, Diabetes, 50, 921, 10.2337/diabetes.50.5.921
Thompson, 2001, The acute versus the chronic response to exercise, Med Sci Sports Exerc, 33, S438, 10.1097/00005768-200106001-00012
Burstein, 1990, Effect of an acute bout of exercise on glucose disposal in human obesity, J Appl Physiol, 69, 299, 10.1152/jappl.1990.69.1.299
Perseghin, 1996, Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects, N Engl J Med, 335, 1357, 10.1056/NEJM199610313351804
Devlin, 1987, Enhanced peripheral and splanchnic insulin sensitivity in NIDDM men after single bout of exercise, Diabetes, 36, 434, 10.2337/diab.36.4.434
Mikines, 1988, Effect of physical exercise on sensitivity and responsiveness to insulin in humans, Am J Physiol, 254, E248
Laaksonen, 2000, Aerobic exercise and the lipid profile in type 1 diabetic men: a randomized controlled trial, Med Sci Sports Exerc, 32, 1541, 10.1097/00005768-200009000-00003
Knowler, 2002, Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin, N Engl J Med, 346, 393, 10.1056/NEJMoa012512
Tuomilehto, 2001, Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance, N Engl J Med, 344, 1343, 10.1056/NEJM200105033441801
Anderson, 2003, Importance of weight management in type 2 diabetes: review with meta-analysis of clinical studies, J Am Coll Nutr, 22, 331, 10.1080/07315724.2003.10719316
Kelley, 1993, Relative effects of calorie restriction and weight loss in noninsulin-dependent diabetes mellitus, J Clin Endocrinol Metab, 77, 1287
Pan, 1997, Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study, Diabetes Care, 20, 537, 10.2337/diacare.20.4.537
Chiasson, 2003, Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial, JAMA, 290, 486, 10.1001/jama.290.4.486
2006, Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial, Lancet, 368, 1096, 10.1016/S0140-6736(06)69420-8
Zinman, 2010, Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study, Lancet, 376, 103, 10.1016/S0140-6736(10)60746-5
DeFronzo R. ACTosNOWfor the prevention of diabetes (ACT NOW) study. Oral presentation at: American Diabetes Association 68th Scientific Sessions. June 9, 2008; San Francisco, CA.
Torgerson, 2004, XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomised study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients, Diabetes Care, 27, 155, 10.2337/diacare.27.1.155
2007, Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the Look AHEAD trial, Diabetes Care, 30, 1374, 10.2337/dc07-0048
Stefanick, 1999, Physical activity for preventing and treating obesity-related dyslipoproteinemias, Med Sci Sports Exerc, 31, S609, 10.1097/00005768-199911001-00020
Durstine, 2001, Blood lipid and lipoprotein adaptations to exercise: a quantitative analysis, Sports Med, 31, 1033, 10.2165/00007256-200131150-00002
Leon, 2001, Response of blood lipids to exercise training alone or combined with dietary intervention, Med Sci Sports Exerc, 33, S502, 10.1097/00005768-200106001-00021
Carroll, 2004, What is the relationship between exercise and metabolic abnormalities?, Sports Med, 34, 371, 10.2165/00007256-200434060-00004
Halbert, 1999, Exercise training and blood lipids in hyperlipidemic and normolipidemic adults: a meta-analysis of randomized, controlled trials, Eur J Clin Nutr, 53, 514, 10.1038/sj.ejcn.1600784
Ballantyne, 1982, The effect of moderate physical exercise on the plasma lipoprotein subfractions of male survivors of myocardial infarction, Circulation, 65, 913, 10.1161/01.CIR.65.5.913
Stubbe, 1983, Plasma lipoproteins and lipolytic enzyme activities during endurance training in sedentary men: changes in high-density lipoprotein subfractions and composition, Metabolism, 32, 1120, 10.1016/0026-0495(83)90058-6
Kodama, 2007, Effect of aerobic exercise training on serum levels of high-density lipoprotein cholesterol: a meta-analysis, Arch Intern Med, 167, 999, 10.1001/archinte.167.10.999
Lamarche, 1997, Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men: prospective results from the Quebec Cardiovascular Study, Circulation, 95, 69, 10.1161/01.CIR.95.1.69
Kraus, 2002, Effects of the amount and intensity of exercise on plasma lipoproteins, N Engl J Med, 347, 1483, 10.1056/NEJMoa020194
Dattilo, 1992, Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis, Am J Clin Nutr, 56, 320, 10.1093/ajcn/56.2.320
Xydakis, 2004, Adiponectin, inflammation, and the expression of the metabolic syndrome in obese individuals: the impact of rapid weight loss through caloric restriction, J Clin Endocrinol Metab, 89, 2697, 10.1210/jc.2003-031826
Whelton, 2002, Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials, Ann Intern Med, 136, 493, 10.7326/0003-4819-136-7-200204020-00006
Kelley, 1995, Effects of aerobic exercise in normotensive adults: a brief meta-analytic review of controlled clinical trials, South Med J, 88, 42, 10.1097/00007611-199501000-00005
Kelley, 1999, Aerobic exercise and resting blood pressure among women: a meta-analysis, Prev Med, 28, 264, 10.1006/pmed.1998.0417
Arroll, 1992, Does physical activity lower blood pressure: a critical review of the clinical trials, J Clin Epidemiol, 45, 439, 10.1016/0895-4356(92)90093-3
Hagberg, 2000, The role of exercise training in the treatment of hypertension: an update, Sports Med, 30, 193, 10.2165/00007256-200030030-00004
Fagard, 1999, Physical activity in the prevention and treatment of hypertension in the obese, Med Sci Sports Exerc, 31, S624, 10.1097/00005768-199911001-00022
Cornelissen, 2005, Effects of endurance training on blood pressure, blood pressure-regulating mechanisms, and cardiovascular risk factors, Hypertension, 46, 667, 10.1161/01.HYP.0000184225.05629.51
Neter, 2003, Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials, Hypertension, 42, 878, 10.1161/01.HYP.0000094221.86888.AE
Fagard, 2005, Effects of exercise, diet and their combination on blood pressure, J Hum Hypertens, 19, S20, 10.1038/sj.jhh.1001956
Cook, 1995, Implications of small reductions in diastolic blood pressure for primary prevention, Arch Intern Med, 155, 701, 10.1001/archinte.1995.00430070053006
Feldeisen, 2007, Nutritional strategies in the prevention and treatment of metabolic syndrome, Appl Physiol Nutr Metab, 32, 46, 10.1139/h06-101
Grundy, 2002, Diet composition and the metabolic syndrome: what is the optimal fat intake?, Am J Med, 113, 25S, 10.1016/S0002-9343(01)00988-3
Riccardi, 2000, Dietary treatment of the metabolic syndrome: the optimal diet, Br J Nutr, 83, S143, 10.1017/S0007114500001082
2007
Lichtenstein, 2006, Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee, Circulation, 114, 82, 10.1161/CIRCULATIONAHA.106.176158
Kesäniemi, 2010, Advancing the future of physical activity guidelines in Canada: an independent expert panel interpretation of the evidence, Int J Behav Nutr Phys Activ, 7, 41, 10.1186/1479-5868-7-41
Malik, 2010, Sugar-sweetened beverages, obesity, type 2 diabetes, and cardiovascular risk, Circulation, 121, 1356, 10.1161/CIRCULATIONAHA.109.876185
Harris, 2004, Lifestyle management for type 2 diabetes, Can Fam Physician, 50, 1235
Fleming, 2008, Lifestyle interventions in primary care: systematic review of randomized controlled trials, Can Fam Physician, 54, 1706
Harris, 2003, Lifestyle interventions for type 2 diabetes: relevance for clinical practice, Can Fam Physician, 49, 1618
Lawton, 2008, Exercise on prescription for women aged 40-74 recruited through primary care: two year randomised controlled trial, BMJ, 337, a2509, 10.1136/bmj.a2509
Dale, 2009, Determining optimal approaches for successful weight maintenance: a randomized controlled trial, CMAJ, 180, E39, 10.1503/cmaj.080974
Isaacs, 2007, Exercise Evaluation Randomised Trial (EXERT): a randomised trial comparing GP referral for leisure centre-based exercise, community-based walking and advice only, Health Technol Assess, 11, 1, 10.3310/hta11100
Wing, 2006, A self-regulation program for maintenance of weight loss, N Engl J Med, 355, 1563, 10.1056/NEJMoa061883
Royal
Ryan, 2003, Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes, Control Clin Trials, 24, 610, 10.1016/S0197-2456(03)00064-3
Alexander, 2003, NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older, Diabetes, 52, 1210, 10.2337/diabetes.52.5.1210
Linström, 2003, The Finnish Diabetes Prevention Study (DPS): lifestyle intervention and 3-year results on diet and physical activity, Diabetes Care, 26, 3230, 10.2337/diacare.26.12.3230
Orchard, 2005, The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program, Ann Intern Med, 142, 611, 10.7326/0003-4819-142-8-200504190-00009
Després, 2001, Treatment of obesity: need to focus on high risk abdominally obese patients, BMJ, 322, 716, 10.1136/bmj.322.7288.716
Chaston, 2008, Factors associated with percent change in visceral versus subcutaneous abdominal fat during weight loss: findings from a systematic review, Int J Obesity (Lond), 32, 619, 10.1038/sj.ijo.0803761
Sharma, 2007, Pharmacotherapy for obesity: adults, 176
Adams, 2007, Long-term mortality after gastric bypass surgery, N Engl J Med, 357, 753, 10.1056/NEJMoa066603
Sjöstrom, 2004, Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery, N Engl J Med, 351, 10.1056/NEJMoa035622
Drolet, 2007, Impact of weight-loss medications on the cardiovascular system: focus on current and future anti-obesity drugs, Am J Cardiovasc Drugs, 7, 273, 10.2165/00129784-200707040-00005
Vettor, 2005, Effect of sibutramine on weight management and metabolic control in type 2 diabetes: a meta-analysis of clinical studies, Diabetes Care, 28, 942, 10.2337/diacare.28.4.942
James, 2010, Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects, N Engl J Med, 363, 905, 10.1056/NEJMoa1003114
Sjöström, 2007, Effects of bariatric surgery on mortality in Swedish obese subjects, N Engl J Med, 357, 741, 10.1056/NEJMoa066254
Nguyen, 2004, The relationship between hospital volume and outcome in bariatric surgery at academic medical centers, Ann Surg, 240, 586, 10.1097/01.sla.0000140752.74893.24
2008, Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis, Lancet, 371, 117, 10.1016/S0140-6736(08)60104-X
Downs, 1998, Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS, JAMA, 279, 1615, 10.1001/jama.279.20.1615
Gisberg, 2010, Effects of combination lipid therapy in type 2 diabetes mellitus, N Engl J Med, 362, 1563, 10.1056/NEJMoa1001282
Keech, 2006, Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomized controlled trial, Lancet, 366, 1849
2000, Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease, Circulation, 102, 21, 10.1161/01.CIR.102.1.21
Rubins, 1999, Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol, N Engl J Med, 341, 410, 10.1056/NEJM199908053410604
Schwartz, 2009, Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome, Am Heart J, 158, 896, 10.1016/j.ahj.2009.09.017
Kannel, 1991, The epidemiology of impaired glucose tolerance and hypertension, Am Heart J, 121, 1268, 10.1016/0002-8703(91)90432-H
Cushman, 2010, Effects of intensive blood-pressure control in type 2 diabetes mellitus, N Engl J Med, 362, 1575, 10.1056/NEJMoa1001286
Holman, 2010, Effect of nateglinide on the incidence of diabetes and cardiovascular events, N Engl J Med, 362, 1463, 10.1056/NEJMoa1001122
2008, Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial, Diabetes Care, 31, 1007, 10.2337/dc07-1868
Dagenais, 2006, Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials, Lancet, 368, 581, 10.1016/S0140-6736(06)69201-5
2002, Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic, JAMA, 288, 2981, 10.1001/jama.288.23.2981
Verdecchia, 2004, Adverse prognostic significance of new diabetes in treated hypertensive subjects, Hypertension, 43, 963, 10.1161/01.HYP.0000125726.92964.ab
Bakris, 2006, Differences in glucose tolerance between fixed-dose antihypertensive drug combinations in people with metabolic syndrome, Diabetes Care, 29, 2592, 10.2337/dc06-1373
Poulter, 2005, Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA), Lancet, 366, 907, 10.1016/S0140-6736(05)67186-3
Jamerson, 2008, Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients, N Engl J Med, 359, 2417, 10.1056/NEJMoa0806182
McMurray, 2010, Effect of valsartan on the incidence of diabetes and cardiovascular events, N Engl J Med, 362, 1477, 10.1056/NEJMoa1001121
2002, Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients, BMJ, 324, 71, 10.1136/bmj.324.7329.71
Berger, 2006, Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials, JAMA, 295, 306, 10.1001/jama.295.3.306
Hansson, 1998, Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial, Lancet, 351, 1755, 10.1016/S0140-6736(98)04311-6
De Berardis, 2009, Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials, BMJ, 339, b4531, 10.1136/bmj.b4531
2009, Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement, Ann Intern Med, 150, 396, 10.7326/0003-4819-150-6-200903170-00008
Mottillo, 2008, Behavioural interventions for smoking cessation: a meta-analysis of randomized controlled trials, Eur Heart J, 30, 718, 10.1093/eurheartj/ehn552
Eisenberg, 2008, Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials, CMAJ, 179, 135, 10.1503/cmaj.070256
2008
Liu, 2006, Characteristics and prevalence of the metabolic syndrome among three ethnic groups in Canada, Int J Obes (Lond), 30, 669, 10.1038/sj.ijo.0803179
Anand, 2000, Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE), Lancet, 356, 279, 10.1016/S0140-6736(00)02502-2
2004, Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies, Lancet, 363, 157, 10.1016/S0140-6736(03)15268-3
Deurenberg-Yap, 2002, Elevated body fat percentage and cardiovascular risks at low body mass index levels among Singaporean Chinese, Malays and Indians, Obes Rev, 3, 209, 10.1046/j.1467-789X.2002.00069.x
Razak, 2007, Defining obesity cut points in a multiethnic population, Circulation, 115, 2111, 10.1161/CIRCULATIONAHA.106.635011
Singh, 2005, Clinical characteristics of South Asian patients hospitalized with heart failure, Ethn Dis, 15, 615
Enas, 1996, Meeting of the International Working Group on Coronary Artery Disease in South Asians, Indian Heart J, 48, 727
Gupta, 2006, South Asians and cardiovascular risk: what clinicians should know, Circulation, 113, e924, 10.1161/CIRCULATIONAHA.105.583815
Sheth, 1999, Cardiovascular mortality among Canadians of European, South Asian and Chinese origin from 1979 to 1993: an analysis of 1.2 million deaths, CMAJ, 161, 132
Gupta, 2002, Risk factors, hospital management and outcomes after myocardial infarction in South Asian Canadians and matched control subjects, CMAJ, 166, 717
Joshi, 2007, Risk factors for early myocardial infarction in South Asians compared with individuals in other countries, JAMA, 297, 286, 10.1001/jama.297.3.286
Gupta, 2001, Canadian South Asians have more severe angiographic coronary disease than European Canadians despite having fewer risk factors, Can J Cardiol, 17, 226C
Brister, 2007, Ethnic diversity: South Asian ethnicity is associated with increased coronary artery bypass grafting mortality, J Thorac Cardiovasc Surg, 133, 150, 10.1016/j.jtcvs.2006.05.068
Gupta, 2006, Is South Asian ethnicity an independent cardiovascular risk factor?, Can J Cardiol, 22, 193, 10.1016/S0828-282X(06)70895-9
Chiu, 2010, Comparison of cardiovascular risk profiles among ethnic groups using population health surveys between 1996 and 2007, CMAJ, 182, E301, 10.1503/cmaj.091676
Leenan, 2008, Results of the Ontario Survey on the Prevalence and Control of Hypertension, CMAJ, 178, 1441, 10.1503/cmaj.071340
Creatore, 2010, Age- and sex-related prevalence of diabetes mellitus among immigrants to Ontario, Canada, CMAJ, 182, 781, 10.1503/cmaj.091551
Jafar, 2006, Prevalence of overweight and obesity and their association with hypertension and diabetes mellitus in an Indo-Asian population, CMAJ, 175, 1071, 10.1503/cmaj.060464
Mente, 2010, Ethnic variation in adiponectin and leptin levels and their association with adiposity and insulin resistance, Diabetes Care, 33, 1629, 10.2337/dc09-1392
Deurenberg-Yap, 2001, Relationships between indices of obesity and its morbidities in multi-ethnic Singapore, Int J Obes, 25, 1554, 10.1038/sj.ijo.0801739
Pan, 2004, Body mass index and obesity-related metabolic disorders in Taiwanese and US whites and blacks: implications for definitions of overweight and obesity in Asians, Am J Clin Nutr, 79, 31, 10.1093/ajcn/79.1.31
Gu, 2008, Blood pressure and risk of cardiovascular disease in Chinese men and women, Am J Hypertens, 21, 265, 10.1038/ajh.2007.59
Ko, 1999, Prediction of hypertension, diabetes, dyslipidaemia or albuminuria using simple anthropometric indexes in Hong Kong Chinese, Int J Obes Relat Metab Disord, 23, 1136, 10.1038/sj.ijo.0801043
He, 2001, Body fat determination by dual energy X-ray absorptiometry and its relation to body mass index and waist circumference in Hong Kong Chinese, Int J Obes Relat Metab Disord, 25, 748, 10.1038/sj.ijo.0801612
Deurenberg, 1999, The impact of body build on the relationship between body mass index and percent body fat, Int J Obes Relat Metab Disord, 23, 537, 10.1038/sj.ijo.0800868
Teo, 2009, Potentially modifiable risk factors associated with myocardial infarction in China: the INTERHEART China study, Heart, 95, 1857, 10.1136/hrt.2008.155796
Ko, 2010, Hypoadiponectinaemia enhances waist circumference as a predictor of glucose intolerance and clustering of risk factors in Chinese men, Diabetes Metab, 36, 192, 10.1016/j.diabet.2009.11.007
Wang, 2010, Are the associations of plasma leptin and adiponectin with type 2 diabetes independent of obesity in older Chinese adults?, Diabetes Metab Res Rev, 26, 109, 10.1002/dmrr.1060
Anand, 2001, Risk factors, atherosclerosis, and cardiovascular disease among Aboriginal people in Canada: the Study of Health Assessment and Risk Evaluation in Aboriginal Peoples (SHARE-AP), Lancet, 358, 1147, 10.1016/S0140-6736(01)06255-9
Ley, 2008, Adipokines and incident type 2 diabetes in an Aboriginal Canadian population: the Sandy Lake Health and Diabetes Project, Diabetes Care, 31, 1410, 10.2337/dc08-0036
Kaler, 2006, High rates of the metabolic syndrome in a first nations community in western Canada: prevalence and determinants in adults and children, Int J Circumpolar Health, 65, 389, 10.3402/ijch.v65i5.18139
Harris, 2002, The impact of diabetes on cardiovascular risk factors and outcomes in a native Canadian population, Diabetes Res Clin Pract, 55, 165, 10.1016/S0168-8227(01)00316-3
Naqshbandi, 2008, Global complication rates of type 2 diabetes in Indigenous peoples: a comprehensive review, Diabetes Res Clin Pract, 82, 1, 10.1016/j.diabres.2008.07.017
Green, 2003, The epidemiology of diabetes in the Manitoba-registered First Nation population: current patterns and comparative trends, Diabetes Care, 26, 1993, 10.2337/diacare.26.7.1993
Dyck, 2010, Epidemiology of diabetes mellitus among First Nations and non-First Nations adults, CMAJ, 182, 249, 10.1503/cmaj.090846
Harris, 1997, The prevalence of NIDDM and associated risk factors in native Canadians, Diabetes Care, 20, 185, 10.2337/diacare.20.2.185
Harris, 2009, Comparison of the clinical management of type 2 diabetes in Canada's First Nations peoples to national guidelines: the CIRCLE study [abstract], Can J Diabetes, 33, 202, 10.1016/S1499-2671(09)33053-1
Amed, 2010, Type 2 diabetes, medication-induced diabetes, and monogenic diabetes in Canadian children: a prospective national surveillance study, Diabetes Care, 33, 786, 10.2337/dc09-1013
Katzmarzyk, 2008, Obesity and physical activity among Aboriginal Canadians, Obesity (Silver Spring), 16, 184, 10.1038/oby.2007.51
Gracey, 2009, Indigenous health part 1: Determinants and disease patterns, Lancet, 374, 65, 10.1016/S0140-6736(09)60914-4
Anand, 2006, Social disadvantage and cardiovascular disease: development of an index and analysis of age, sex, and ethnicity effects, Int J Epidemiol, 35, 1239, 10.1093/ije/dyl163
Anderson, 2006, Indigenous health in Australia, New Zealand, and the Pacific, Lancet, 367, 1775, 10.1016/S0140-6736(06)68773-4
Martens, 2007, Diabetes and adverse outcomes in a First Nations population: associations with healthcare access, and socioeconomic and geographical factors, Can J Diabetes, 31, 223, 10.1016/S1499-2671(07)13009-4
Retnakaran, 2005, Cigarette smoking and cardiovascular risk factors among Aboriginal Canadian youths, CMAJ, 173, 885, 10.1503/cmaj.045159
Daniel, 2010, Environments and cardiometabolic diseases in Aboriginal populations, Heart Lung Circ, 19, 306, 10.1016/j.hlc.2010.01.005
2008, Type 2 diabetes in high-risk ethnic populations, Can J Diabetes, 32, S191
Anand, 2004, C-reactive protein as a screening test for cardiovascular risk in a multiethnic population, Arterioscler Thromb Vasc Biol, 24, 1509, 10.1161/01.ATV.0000135845.95890.4e
McQueen, 2008, Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study, Lancet, 19, 224, 10.1016/S0140-6736(08)61076-4
Grewal, 2008, Prevalence and predictors of subclinical atherosclerosis among asymptomatic “low risk” individuals in a multiethnic population, Atherosclerosis, 197, 435, 10.1016/j.atherosclerosis.2007.06.020
Hux, 2003, Patterns of prevalence and incidence of diabetes, 1.1
2000
2005
Gucciardi, 2009, Exploration of the relationship between household food insecurity and diabetes in Canada, Diabetes Care, 32, 2218, 10.2337/dc09-0823
Seligman, 2010, Food insecurity is associated with chronic disease among low-income NHANES participants, J Nutr, 140, 304, 10.3945/jn.109.112573
Liao, 2007, Safety and efficacy of statins in Asians, Am J Cardiol, 99, 410, 10.1016/j.amjcard.2006.08.051